Phase I/II Trial of Abemaciclib with Gemcitabine for Advanced Soft Tissue Sarcoma
A phase I/II trial is evaluating the safety and efficacy of abemaciclib combined with gemcitabine versus gemcitabine with docetaxel in patients with advanced soft tissue sarcoma.